Sartorius (SARTF) Projected to Post Earnings on Thursday
by Danessa Lincoln · The Markets DailySartorius (OTCMKTS:SARTF – Get Free Report) is expected to be posting its resultson Thursday, July 23rd. Analysts expect the company to post earnings of $1.56 per share and revenue of $1.0658 billion for the quarter.
Sartorius Price Performance
Sartorius stock opened at $212.80 on Thursday. The stock has a 50-day simple moving average of $211.21 and a 200-day simple moving average of $220.42. The company has a market capitalization of $7.28 billion, a P/E ratio of 98.98 and a beta of 0.98. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.49 and a current ratio of 0.95. Sartorius has a fifty-two week low of $181.58 and a fifty-two week high of $227.00.
About Sartorius
Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.
The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.
Recommended Stories
- Five stocks we like better than Sartorius
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings